Founded in 2021, AMPLY Discovery is a biotechnology company that combines machine learning and synthetic biology to accelerate the discovery of novel biologic drugs and nutraceutical candidates. Leveraging its proprietary in silico and in vitro hybrid platform, the company identifies best-in-class molecules aimed at addressing some of humanity’s greatest challenges — including cancer, multidrug-resistant infections, and metabolic diseases.